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A metaproteomics approach comprising two-dimensional gel electrophoresis and matrix-assisted laser
desorption ionization–time of flight (mass spectrometry) was applied to the largely uncultured infant fecal
microbiota for the first time. The fecal microbial metaproteome profiles changed over time, and one
protein spot contained a peptide sequence that showed high similarity to those of bifidobacterial
transaldolases.
The human gastrointestinal tract is rapidly colonized during
the first days of life by microbes (4, 10) which ultimately con-
tribute significantly to host nutrition and immunity among
other beneficial effects (1, 8). Analysis of 16S ribosomal DNA
clone libraries revealed numerous undescribed species in in-
testinal samples, emphasizing the importance of techniques
that bypass cultivation of microbiota (3, 4, 15, 17, 20) such as
proteomics. So far there have been two reports of the use of
metaproteomics to characterize complex bacterial ecosystems,
illustrating the feasibility of this approach in analyzing complex
ecosystems (12, 19). In the present study we investigated the
potential use of metaproteomics for characterization of the
human fecal microbiota.
Dynamics of the intestinal microbiota. The relatively simple
infant fecal ecosystem was chosen for this study as it is domi-
nated by bifidobacteria, which were used in this study to opti-
mize the protein isolation and two-dimensional (2D) gel pro-
cedures (data not shown). Informed consent was obtained
from parents for use of the fecal samples of their infants. Infant
fecal samples containing high bifidobacterial content were se-
lected by bifidobacterium-specific fluorescent in situ hybridiza-
tion (6, 22). Infants A (8 days old) and B (117 days old)
harbored 45% and 63% bifidobacteria in the total microbiota,
respectively. PCR-denaturing gradient gel electrophoresis
(DGGE) (14, 21, 23) of the 16S rRNA gene was performed to
monitor the total bacterial community (Fig. 1). The profiles
were relatively simple (Fig. 1) (4), as expected, and the pre-
dominance of bifidobacteria was supported by the presence of
abundant 16S rRNA gene amplicons that comigrated with the
control Bifidobacterium longum strain and was confirmed by
sequencing (14).
Metaproteome production of infant fecal microbiota. Fecal
samples were collected from the infants prior to weaning: for
infant A, at days 8, 24, and 41, and for infant B, at days 103, 117,
and 144. Microbial cells were released from the feces and washed
as previously described (5, 22). The bead beating method was
confirmed to be applicable for protein extraction of infant fecal
microbiota containing bifidobacteria (data not shown), as ex-
pected from previous systematic studies (5, 14, 20, 23, 24). Total
soluble protein was obtained by three treatments of 45 s of bead
beating (FastPrep; Qbiogene), interspersed by 1 min on ice, in
500-l isoelectric focusing (IEF) buffer (Fluka, Switzerland) (10
M urea) containing 2% CHAPS (3-[(3-cholamidopropyl)-dimeth-
ylammonio]-1-propanesulfonate) (Roche, Switzerland), 0.65 mM
dithiothreitol (DTT) (Sigma, Switzerland), 0.2% Biolytes 3/10
(Bio-Rad), Pefabloc Sc (Fluka), and glass beads (Sigma) (0.1
mm). Protein concentrations were determined using a 2-D Quant
kit (Amersham Biosciences). Each protein sample (100 g) was
loaded onto 11-cm immobilized pH gradient (IPG) ReadyStrips
(Bio-Rad) (pH 4 to 7) and rehydrated for 12 h. IEF was carried
out for 98,000 Vh (Protean IEF; Bio-Rad). Reduction and alkyl-
ation of proteins were performed prior to electrophoresis in the
second dimension by incubating for 10 min in 6 M Urea–0.1 M
Tris-HCl (pH 8.8)–2% (wt/vol) sodium dodecyl sulfate (SDS)
with 130 mM DTT followed by a 10 min incubation in the pres-
ence of 216 mM iodoacetamide (instead of DTT). The IPG strip
was positioned on an SDS-polyacrylamide electrophoresis gel
(Criterion gel, Bio-Rad) (12.5% polyacrylamide) with 1% low
melting agarose in 40 mM Tris-HCl (pH 6.8). Electrophoresis was
run at 100 V and 30 W. Silver staining was performed as described
previously (16). Protein maps were scanned with a GS-800 den-
sitometer (Bio-Rad) and analyzed with PDQuest software (Bio-
Rad). Triplicate 2D gels for each sample were grouped. For each
infant, three groups, each representing one time point in life, were
compared using the quantitative function within PDQuest soft-
ware. The mean coefficient of variation (CV) (standard deviation/
mean  100) is a quantitative index for variation of quantities
among matched spots and was computed for gel-to-gel variations
within each replicate group. More than 200 protein spots were
visualized on each gel. A comparison of gels of infant A revealed
changes in number and intensities of protein spots during the 33
days, although the patterns remained similar (Fig. 2A to C). In
order to clearly demonstrate the changes a section of the gel
corresponding to each time point was enlarged (Fig. 3). Compar-
isons of differential protein production values with percent CV
values for various time points for the marked spots are illustrated
with bar graphs (Fig. 3C). The metaproteome profiles of infant A
(Fig. 2A to C) were different from those of infant B (see, e.g., Fig.
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2D) in accordance with the uniqueness of each individual’s mi-
crobiota (20), as was also observed in the PCR-DGGE profiles
obtained as described above.
Identification of proteins. A total of 55 protein spots were
excised from the infant A 2D gel at day 41 (Fig. 3A). Peptides
were extracted after tryptic digestion and analyzed by matrix-
assisted laser desorption ionization–time of flight (mass spec-
trometry) [MALDI-TOF (MS)] (2) (Applied Biosystems 4700
proteomics analyzer; Technology Facility, Department of Bi-
ology, The University of York, York, United Kingdom),
which provided a catalogue of 21 good mass peptide finger-
prints. Peptide sequences were searched using BLASTP,
with the default settings of the “Search for short, nearly
exact matches” function, as well as MS-Pattern in Protein
Prospector 4.0.5 (The University of California). As ex-
pected, the peptides’ mass spectra showed low similarity to
those of database entries and no similarities to those of
human proteins. The mean differential protein amounts of
the 21 spots with clean signals for days 8, 24, and 41 are
indicated in Fig. 3A and presented in Table 1. MALDI-TOF
(MS) of spots 1, 2, 7, and 11 was performed for de novo
peptide sequencing (Fig. 3B), which resulted in determina-
tion of 11 N-terminal sequences that shared similarity to
those of bacterial proteins, a viral protein, and four eukaryal
proteins, but the collective sequences were not significantly
similar to any previously reported.
One complete peptide fragment (ELAEATDFVDGR) of
FIG. 1. PCR-DGGE profiles of regions V8 to V6 of 16S rRNA
genes of fecal samples from two infants at different ages (infant A, 8 to
41 days; infant B, 128 to 191 days), reflecting the predominant bacterial
community. The bands in the box represent amplicons of bifidobac-
terial species, including Bifidobacterium longum DSM 20219. *, start of
weaning period for infant A. Sampling days for protein extraction are
shown in bold. marker, mix of DNA size standards; bifspecific product,
amplicon of 16S rRNA gene of B. longum DSM 20219.
FIG. 2. Silver-stained 2D gels of fecal samples from infant A at the ages of 8 days (A), 24 days (B), and 41 days (C) and from infant B at 117
days (D); data were obtained using IPG (pH 4 to 7). MW, molecular weight.
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protein spot 4 gave a result showing high-level database
matches of 91% identity (i.e., one mismatch) with the Bifido-
bacterium infantis and B. longum NCC2705 transaldolases and
83% identity with the DJO10A transaldolase. Production for
this protein spot was relatively high at day 8 but increased
approximately 10-fold and 6-fold at days 24 and 41, respec-
tively, possibly due to the increase in numbers and activity of
bifidobacteria in the infants’ microbiota, based on PCR-
DGGE (Table 1 and Fig. 1). The data obtained for the diges-
tion sites of trypsin and the theoretical pI (4.87) and molecular
mass (39.6 kDa) of the B. infantis transaldolase protein agreed
with the position of the protein spot in the 2D gel (Fig. 3A).
This transaldolase gene is a common target for PCR used to
detect and enumerate bifidobacteria (13). Transaldolase was
identified in a proteomic study by Vitali et al. (18) of B. infantis
B107, where it represented, together with nine other proteins,
the most abundant portion of the proteome. The dominance of
the (tentatively identified) bifidobacterial transaldolase protein
in the feces of a newborn infant may explain its detection by a
metaproteomics approach.
FIG. 3. (A) Silver-stained 2D gel of a fecal sample from infant A at the age of 41 days obtained using IPG (pH 4 to 7). The circled protein spots
were excised, and mass fingerprints were obtained by MALDI-TOF (MS). Table 1 shows the quantity of the selected protein spots. MW, molecular
weight. (B) Areas of interest enclosed in the boxes are enlarged from gels of samples from infant A at the ages of 8 (I), 24 (II), and 41 (III) days.
The circled protein spots (1, 2, 7, and 11) gave good peptide sequencing results with MALDI-TOF (MS). (C) The diagrams demonstrate changes
in intensity of the protein spots (1, 2, 7, and 11) (see panel BI) with percent CV values at ages 8, 24, and 41 days.
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Perspectives. For the first time, reproducible 2D gels,
extraction of proteins, and tentative identification using
MALDI-TOF (MS) demonstrated the applicability of the
proteomics approach for the complex intestinal ecosystem.
Currently insufficient microbiome sequence information
confounds identification of the proteins, but ongoing meta-
genomic library analysis will enable meaningful identifica-
tion in time (7, 9, 11). Furthermore, peptide mass finger-
prints from sequence data will be sufficient to produce more
statistically valid database matches, as was recently demon-
strated by Ram et al. (12), who matched 6,000 peptide
fragments to DNA sequences of an accompanying meta-
genomic library from a low-complexity natural microbial
biofilm. Metaproteomics approaches may become a useful
tool to monitor the functional products of the microbiota in
feces over time as affected by dietary intervention, length
life, health, and disease.
Nucleotide sequence accession numbers and peptide se-
quences. The bifidobacterial nucleotide sequences of partial
16S rRNA genes have been deposited in the GenBank data-
base under accession no. DQ323457, DQ323458, and DQ323459;
the 11 peptide sequences are DLAVALSENKR, ATNSEL
MHVGVSR, ELAEATDFVDGR, and PSSKVGSGSSGA
GALK (for spot 1), DVAPDLALMHTKLSR (for spot 2),
ADNFEGDDR and TAFTGYETLR (for spot 7), and KTGP
KLFAADEALK, HYGLASDALANGGCVDSVSDSPA, AP
MVALSELER, and TANSELLEAELAR (for spot 11).
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